Wondering if we might be seeing a large investor about to underwrite phase 3 for her-vaxx.
realistically we either need to sell it in full or find some funds.
If the intention is to keep this through phase 3 in house then we will need a partner with deep pockets.
I would be favouring a non pharma related entity so that some form of independence is maintained which supports the “dance card” view of licensing the product to multiple pharmas.
my opinion only DYOR
Ann: Trading Halt, page-73
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.7¢ |
Change
-0.002(2.90%) |
Mkt cap ! $490.4M | |||
| Open | High | Low | Value | Volume |
| 6.9¢ | 7.1¢ | 6.7¢ | $1.445M | 21.03M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 23 | 2363454 | 6.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.8¢ | 14705 | 1 |
View Market Depth
| Last trade - 16.10pm 22/05/2024 (20 minute delay) ? |
|
|||||
|
Last
6.8¢ |
Change
-0.002 ( 1.59 %) |
||||
| Open | High | Low | Volume | ||
| 7.0¢ | 7.1¢ | 6.7¢ | 9797879 | ||
| Last updated 16.01pm 22/05/2024 ? | |||||
| IMU (ASX) Chart |